Infectious Disease · ICD-10: B83.0

Visceral Larva Migrans

INDICATIONS AND USAGE MINTEZOL is indicated for the treatment of: Strongyloidiasis (threadworm) Cutaneous larva migrans (creeping eruption) Visceral larva migra…

Medically reviewed by MedCentralHub Medical Review Board, Licensed Pharmacists & Physicians · May 2026

Check Interactions Browse Medicines

ICD-10 B83.0

Visceral Larva MigransInfectious Disease

Section 01

Overview

INDICATIONS AND USAGE MINTEZOL is indicated for the treatment of: Strongyloidiasis (threadworm) Cutaneous larva migrans (creeping eruption) Visceral larva migrans Trichinosis: Relief of symptoms and fever and a reduction of eosinophilia have followed the use of MINTEZOL during the invasion stage of the disease. Thiabendazole is usually inappropriate as first line therapy for enterobiasis (pinworm). However, when enterobiasis occurs with any of the conditions listed above, additional therapy is not required for most patients. MINTEZOL should be used only in the following infestations when more specific therapy is not available or cannot be used or when further therapy with a second agent is desirable: Uncinariasis (hookworm: Necator americanus and Ancylostoma duodenale ); Trichuriasis (whip...

Key Clinical Points

•Diagnosis typically involves a clinical evaluation, relevant blood tests, and imaging or specialist assessment as indicated by your symptoms and risk profile.
•Risk factors for Visceral Larva Migrans include age, family history, lifestyle factors, and underlying health conditions. Identifying your personal risk can help with early prevention.
•Lifestyle modifications — including regular physical activity, a balanced diet, and weight management — are often a core part of treatment and can help prevent or delay complications.
•There are different types of Visceral Larva Migrans with varying causes, symptoms, and treatment pathways. Your healthcare provider will determine which type applies to you.
•Early recognition of symptoms and prompt medical evaluation significantly improve outcomes. Do not delay seeking care if you notice warning signs.

This information is for educational purposes only. Always consult a qualified healthcare professional for diagnosis and personalized treatment.

Section 02

Signs & Symptoms

symptoms and fever and a reduction of eosinophilia have followed the use of MINTEZOL during the invasion stage of the disease.

Thiabendazole is usually inappropriate as first line therapy for enterobiasis (pinworm).

However, when enterobiasis occurs with any of the conditions listed above, additional therapy is not required for most patients.

MINTEZOL should be used only in the following infestations when more specific therapy is not available or cannot be used or when further therapy with a second agen

Section 03

Causes & Pathophysiology

Section 04

Risk Factors

Section 05

Diagnosis & Testing

Clinical evaluation by a qualified healthcare professional

Confirmation using ICD-10 criteria (B83.0)

Section 09

Lifestyle & Prevention

Prognosis

Prognosis varies by severity, comorbidities, and access to appropriate care. Discuss expected outcomes with a clinician.

Section 10

Frequently Asked Questions

What is Visceral Larva Migrans?

What is the ICD-10 code for Visceral Larva Migrans?

The ICD-10 code is B83.0.

Sources & References

• CDC (Centers for Disease Control) — Epidemiology and clinical guidelines for Visceral Larva Migrans
• NIH — National Institutes of Health — Clinical research and disease information
• UpToDate Clinical Decision Support — Evidence-based treatment protocols
• PubMed / MEDLINE — View peer-reviewed studies

Last reviewed by MedCentralHub Medical Review Board · MedCentralHub Editorial Policy

Medical Disclaimer

The information on this page is for educational purposes only and is not intended as medical advice, diagnosis, or treatment. Always consult your doctor or a qualified healthcare provider with any questions about a medical condition.